Cancer Care Center of S. Indiana

514 West Second Street - Bloomington, IN 47402

For information about clinical trials being conducted in Bloomington, IN, please contact Melissa Abbott, RN, BSN at 812-353-2831.

Karuna Konera, MD (Principal Investigator)

Trials at this Location:

Disease: Banking / Biorepository
A Biological Sample Collection Protocol of Patients with and without Metastatic Solid Organ Malignancies - BNK09-138
Status: Open to Accrual 10-06-2009; 124 of 200 accrued.
More Details

Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic - BRE-126
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 21 of 44 accrued.
More Details

Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative - DoD COE-03 (BRE-126)
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 21 of 44 accrued.
More Details

Disease: Lung
A Randomized Double Blind Phase II Trial of Cisplatin plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer - LUN06-113
Status: Open to Accrual - 01-23-2008 - 35 of 74 Patients Accrued
More Details

Disease: Lung
Phase I Study of Amrubicin and Cyclophosphamide in Patients with Advanced Solid Organ Malignancies - LUN07-130
Status: Suspended to control enrollment to cohort; contact PM; Original open date 02/02/09; 34 of 34 Patients Accrued
More Details